PUBLISHER: Polaris Market Research | PRODUCT CODE: 1388080
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1388080
The global AI in medical writing market size is expected to reach USD 2,072.30 million by 2032, according to a new study by Polaris market research. The report "AI in Medical Writing Market Share, Size, Trends, Industry Analysis Report, By Type (Scientific Writing, Clinical Writing, Type Writing), By End-use (Medical Devices, Pharmaceutical, Biotechnology), By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing acceptance of machine learning, particularly Artificial Intelligence (AI), in the healthcare industry is a key driver of market expansion. AI-powered solutions have shown significant potential in improving patient care, diagnostic accuracy, drug discovery, and treatment outcomes, leading to increased adoption by healthcare providers and pharmaceutical companies.
Additionally, the rising demand to reduce healthcare expenditures and the increasing R&D investments by pharmaceutical companies to optimize their processes and reduce costs are driving the market growth. AI-powered medical writing tools and solutions offer the potential to streamline various tasks, increase efficiency, and minimize manual efforts, ultimately leading to cost savings for healthcare organizations and pharmaceutical firms.
During the COVID-19 pandemic, many pharmaceutical companies faced budgetary limitations due to economic uncertainties and healthcare system strain. As a result, they had to reevaluate their spending, including investments in research and development. This led to a reduction in R&D budgets and potentially affected their investment in traditional medical writing resources.
In response to the pandemic's challenges and the growing demand for innovative therapies, medical device, biotechnology, and life science companies recognized the need to invest in medical writers. They saw the potential of AI-powered medical writing tools to streamline and enhance the efficiency of the medical writing process. AI-driven solutions could help medical writers generate accurate and reliable reports, conduct literature reviews faster, and facilitate data extraction and summarization, all of which were essential during the pandemic.
As a result, there was an increasing intention among healthcare companies to boost their investment in AI-powered medical writing solutions to address the evolving demands of the healthcare industry during the COVID-19 pandemic and beyond. This increasing demand for AI in the healthcare industry was driven by the need for innovative and efficient solutions to cope with the challenges posed by the pandemic and to accelerate the development and dissemination of critical medical information.
Typewriting segment held the largest share, as it is compulsory to submit all regulatory document requirements to the agencies, and maintenance of electronic health records
Pharmaceutical segment holds the largest share, as drug approval process requires several regulatory filings, documentation, and electronic records of clinical trials
North holds the largest share, owing to presence of companies engaged in regulatory films with innovative services, and increasing investments on drug trials
The global key market players include: Parexel International, Trilogy Writing & Consulting, Freyr, Cactus Communications, and GENINVO.
Polaris market research has segmented the AI in medical writing market report based on type, end use, and region: